For patients with metastatic poorly differentiated large cell neuroendocrine carcinoma of the lung, do you typically use NSCLC or SCLC regimens?

Earlier Studies have shown controversial results. Some show that small cell lung cancer-based regimen concluded better outcome; however, more recently, gemcitabine-platinum therapy in specific and NSCLC-based regimens led to a better outcome.

We reported a retrospective study showing no statistically...